Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 15301 - 15325 of 15504 in total

2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide

Experimental

AL7182

Experimental

1-(N-Imidazolyl)-2-Hydroxy-2-(2,3-Dichlorophenyl)Octane

Experimental

4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid

Experimental

PAS219

Experimental

FR239087

Experimental

4-Fluorophenethyl Alcohol

Experimental

Phenacetin

Phenacetin was withdrawn from the Canadian market in June 1973 due to concerns regarding nephropathy (damage to or disease of the kidney).
Withdrawn

1,3,5-trichlorobenzene

Experimental

4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid

Experimental

1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea

Experimental

N-(Chlorophenyl)-N'-hydroxyguanidine

Experimental

(R)-4-Nitrostyrene oxide

Experimental

Cannabinor

Cannabinor, a synthetic CB2-selective agonist, is in Phase 2 clinical testing as an analgesic.
Investigational

Indisulam

Investigational

N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE

Experimental

4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide

Experimental

2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE

Experimental

4-(2-aminoethyl)-2-ethylphenol

Experimental

(1R)-4-(3-phenoxyphenyl)-1-phosphonobutane-1-sulfonic acid

Experimental

Bromamphenicol

Experimental

4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE

Experimental

Decyl(dimethyl)phosphine oxide

Experimental

N-(3,5-dibromo-4-hydroxyphenyl)-4-hydroxy-3,5-dimethylbenzamide

Experimental

(S)-econazole

Experimental
Displaying drugs 15301 - 15325 of 15504 in total